Biography

Education: 

Rutgers University 2011-2015 Biomedical Informatics PhD

 

Fellowship:

UT Southwestern  2016-2018 Clinical Genetics and Genomics 

UT Southwestern  2018-2019 Laboratory Genetics and Genomics

Education

Undergraduate School
University of Texas at San Antonio (1990)
Graduate School
Rutgers University, the State University of New Jersey (2009)
Graduate School
Rutgers University, the State University of New Jersey (2015)
Fellowship
Pathology - Clinical Cytogenetics (2018), Cytogenetics

Research Interest

  • Clinical Genetics and Genomics
  • Hematolymphoid Disorders
  • Statistical Learning

Publications

Featured Publications LegendFeatured Publications

A Combined Biomarker of Bright CD38 and MYC =55% Is Highly Predictive of Double-/Triple-Hit High-Grade B-Cell Lymphoma.
Alsuwaidan A, Koduru P, Fuda F, Manuel Jaso J, Chen M, Rosado F, Luu HS, Sweed N, Garcia R, Doucet M, Desai NB, Kumar KA, Awan FT, Ramakrishnan Geethakumari P, Chen W, Am J Clin Pathol 2022 May
Rhabdomyosarcoma With Epithelioid Features And NSD3::FOXO1 Fusion: Evidence For Reconsideration Of Previously Reported FOXO1::FGFR1 Fusion.
Rakheja D, Park JY, Yang MS, Martinez DP, Koduru P, Wilson KS, Garcia R, Uddin N, Int J Surg Pathol 2022 May 10668969221098084
Automated classification of cytogenetic abnormalities in hematolymphoid neoplasms.
Cox A, Park C, Koduru P, Wilson K, Weinberg O, Chen W, García R, Kim D, Bioinformatics 2021 Dec
Identification of potential antiviral compounds against SARS-CoV-2 structural and non structural protein targets: A pharmacoinformatics study of the CAS COVID-19 dataset.
García R, Hussain A, Koduru P, Atis M, Wilson K, Park JY, Toby I, Diwa K, Vu L, Ho S, Adnan F, Nguyen A, Cox A, Kirtek T, García P, Li Y, Jones H, Shi G, Green A, Rosenbaum D, Comput Biol Med 2021 06 133 104364
Development and Clinical Validation of a Multiplex Gene Fusion Assay
Rolando García, PhD, Nirav Patel, PhD,Naseem Uddin, MD, Jason Y. Park,MD, PhD Lab Med 2020 1-7
Bright CD38 Expression by Flow Cytometric Analysis Is a Biomarker for Double/Triple Hit Lymphomas with a Moderate Sensitivity and High Specificity.
Alsuwaidan A, Pirruccello E, Jaso J, Koduru P, Garcia R, Krueger J, Doucet M, Chaudhry R, Fuda F, Chen W Cytometry B Clin Cytom 2019 Feb
Clinical impact of MYC abnormalities in plasma cell myeloma.
García R, Chen W, Koduru P Cancer Genet 2018 Dec 228-229 115-126
Cytogenetic and Cytogenomic Microarray Characterization of Chromothripsis in Chromosome 8 Affecting MOZ/NCOA2 (TIF2), FGFR1, RUNX1T1, and RUNX1 in a Pediatric Acute Myeloid Leukemia.
Koduru PR, Wilson K, Wen J, Garcia R, Patel S, Monaghan SA J. Pediatr. Hematol. Oncol. 2017 Jan
Acquisition of a t(11;14)(q13;q32) in clonal evolution in a follicular lymphoma with a t(14;18)(q32;q21) and t(3;22)(q27;q11.2).
Koduru PR, Chen W, Garcia R, Fuda F Cancer Genet 2015 Mar
Myeloid neoplasm with t(3;8)(q26;q24): report of six cases and review of the literature.
Xu X, Su M, Levy NB, Mohtashamian A, Monaghan S, Kaur P, Zaremba C, Garcia R, Broome HE, Dell'aquila ML, Wang HY Leuk. Lymphoma 2014 Feb